Acylin Therapeutics' Series A Round

Acylin Therapeutics raised a round of funding on December 16, 2010.

Aylin Therapeutics is a biotechnology company focused on developing inhibitors of cellular acylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and ne…

Articles about Acylin Therapeutics' Series A Round: